ym 09151-2 has been researched along with bromperidol in 3 studies
| Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (bromperidol) | Trials (bromperidol) | Recent Studies (post-2010) (bromperidol) |
|---|---|---|---|---|---|
| 249 | 6 | 13 | 109 | 23 | 19 |
| Protein | Taxonomy | ym 09151-2 (IC50) | bromperidol (IC50) |
|---|---|---|---|
| N-acetyltransferase Eis | Mycobacterium tuberculosis H37Rv | 0.52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Ono, S; Otani, K; Suzuki, A | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Ono, S; Otani, K; Suzuki, A; Yasui, N | 1 |
| Furukori, H; Inoue, Y; Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Suzuki, A; Yasui-Furukori, N | 1 |
2 trial(s) available for ym 09151-2 and bromperidol
| Article | Year |
|---|---|
No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
Topics: Acute Disease; Alleles; Antipsychotic Agents; Benzamides; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Female; Haloperidol; Humans; Male; Pilot Projects; Polymorphism, Restriction Fragment Length; Receptors, Dopamine D2; Reproducibility of Results; Schizophrenia | 2000 |
No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
Topics: Adult; Benzamides; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia | 2001 |
1 other study(ies) available for ym 09151-2 and bromperidol
| Article | Year |
|---|---|
The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Anxiety; Benzamides; Depression; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia | 2001 |